USFDA Inspects Dr Reddy's Hyderabad R'D Facility
Dec 07, 2023 15:06
Dr Reddy's Laboratories confirms USFDA inspection of its Hyderabad R'D facility. The outcome of the inspection will be disclosed to stock exchanges.
New Delhi, Dec 7 (PTI) Dr Reddy's Laboratories on Thursday said the US health regulator is conducting an inspection of its Hyderabad-based R&D facility.
"We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges," it said in a regulatory filing.
The company proactively discloses the outcome of every USFDA inspection to the stock exchanges immediately after the end of the inspection, it added.
Shares of the company were trading 1.2 per cent up at Rs 5,796.40 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.